Insights
Events

Developments in Pharmaceutical and Biotech Patent Law 2016

12/9/2016
San Francisco, CA

Stephanie Skaff to speak at PLI's Developments in Pharmaceutical and Biotech Patent Law 2016 seminar in San Francisco.

Overview

Pharmaceutical and biotech patent law is an important and rapidly changing practice area, and the program is designed to give you the information you need to maintain your practice edge, concentrating on new developments from 2015 and 2016, and placing them in the context of constantly evolving areas of the law.

Technological innovation, Federal Circuit appellate oversight, and Supreme Court decisions continue to drive significant changes in the law. Several different perspectives on many of the most pressing issues will be offered from very experienced practitioners.

Do not miss this opportunity to fully understand the impact of new appellate decisions on your pharmaceutical and biotechnology patent practice.

What You Will Learn

  • Biosimilars: the biosimilar approval process, regulatory exclusivity and patent litigation over biosimilar applications
  • The Supreme Court’s unmaking the law of willfulness: a return patent opinions and uncertainty
  • Continued development of patentable subject matter jurisprudence under Section 101 and an update on USPTO Patentability Guidelines for patentable subject matter
  • Litigating life sciences patent cases in district courts: strategies for fact and expert discovery, effective Markman presentations and technology tutorials, summary judgment and trial
  • Ethical considerations impacting patent practice

Special Feature:

  • Earn One Hour of Ethics Credit

Firm Highlights

News

Farella Braun + Martel Recognized by Chambers USA 2019

SAN FRANCISCO, April 25, 2019:Farella Braun + Martel announces that Chambers USA has recognized 11 lawyers and five practice areas in the legal directory’s 2019 edition. Practice Area Recognition:  Of note, this year the...

Read More
Publication

What California’s New Security Law Means to Your Business

Commonsense IoT security steps that startups and small business should consider to comply with California’s new law California recently enacted a new law, Senate Bill 327, that requires companies that make Internet of Things...

Read More
Publication

Supreme Court Upholds Constitutionality of Inter Partes Review of Issued Patents

In 2012, Congress created a new procedure that allows the U.S. Patent and Trademark Office to conduct a litigation-like procedure to review and potentially cancel patents. This procedure - inter partes review (“IPR”) - has...

Read More
News

Daily Journal Names Jeff Fisher Among Top IP Lawyers in California

Read More
Publication

Who 'Owns' a Secret? Whether Trade Secret Licensees Have Standing to Sue in California

If the eye-popping damages awards in several recent lawsuits are any indication, companies are increasingly coming to see their private information as one of their most valuable assets—and California juries apparently agree. For example,...

Read More
News

Farella Braun + Martel Attorneys Named 2019 IP Stars by Managing Intellectual Property

SAN FRANCISCO, May 21, 2019: Farella Braun + Martel’s James L. Day , Jeffrey M. Fisher , Eugene Mar , Stephanie P. Skaff and Roderick M. Thompson have been named IP Stars by Managing...

Read More
Publication

Will It Go Forward? First Cannabis Patent Infringement Case Filed in Federal Court

A patent infringement case pending in front of the U.S. District Court for the District of Colorado has the potential to set an important precedent that will have ramifications for many of our clients...

Read More